Add like
Add dislike
Add to saved papers

Myofascial referred-pain data provide physiologic evidence of acupuncture meridians.

Journal of Pain 2009 July
UNLABELLED: Recently published data suggest substantial anatomic, clinical, and physiologic (referred pain to meridian) overlap of myofascial trigger points and acupuncture points, particularly in the treatment of pain disorders. This qualitative study examines whether myofascial referred-pain data from the Trigger Point Manual can provide independent physiologic evidence of acupuncture meridians. Trigger point regions were subdivided from prior, validated trigger point region-classical acupuncture point correspondence results into subsets according to the 12 acupuncture Organs of their anatomically corresponding acupuncture points (Bladder, Gallbladder, Heart, Kidney, Large Intestine, Liver, Lung, Pericardium, Small Intestine, Spleen, Stomach, and Triple Energizer). The referred-pain patterns for each subset of trigger point regions were graphically applied to a virtual human model along with the subset's corresponding acupuncture Principal meridian. All 12 meridian distributions were compared qualitatively with the summed referred-pain distributions of their anatomically corresponding trigger point regions. For all 12 subsets of trigger point regions, their summed referred-pain patterns accurately predicted the distributions of their corresponding acupuncture meridians, particularly in the extremities. The myofascial referred-pain data from the Trigger Point Manual provides independent physiologic evidence of acupuncture meridians. Understanding these meridians may enhance treatment of both pain and non-pain conditions.

PERSPECTIVE: This article demonstrates that myofascial referred-pain data provide independent physiologic evidence of acupuncture meridians. The acupuncture tradition provides pain practitioners with millennia of accumulated clinical experience treating pain (and visceral) disorders and offers the potential for novel pain treatment approaches and understanding of pain neurophysiology.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app